7-3-3-3　ⓔ文献

1. Murphy TF, Parameswaran GI: Moraxella catarrhalis, a human respiratory tract pathogen. Clinical Infectious Diseases, 2009; 49: 124–131.

2. Baker BL, Halder K, et al: Association between pathogens detected using quantitative polymerase chain reaction with airway inflammation in COPD at stable and exacerbations. Chest, 2015; 147: 46–55.

3. Wilkinson TMA, Aris E, et al: A prospective observational cohort study of the seasonal dynamics of airway pathogens in the aetiology of exacerbations in COPD. Thorax, 2017; 72: 919–927.

4. Mayhew D, Devos N, et al: Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations. Thorax, 2018; 73: 422–430.

5. George LM, Haigh RD, et al: Sputum Moraxella catarrhalis strains exhibit diversity within and between COPD subjects. International Journal of COPD, 2018; 13: 3663–3667.

6. Bootsma HJ, van der Heide HG, et al: Analysis of Moraxella catarrhalis by DNA typing: Evidence for a distinct subpopulation associated with virulence traits. J Infect Dis, 2000; 181: 1376–1387.